Neurostimulator Titration Protocol for Rapid Therapeutic Intensity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for titrating neurostimulation therapy, such as vagus nerve stimulation, are time-consuming and inefficient, particularly for patients with chronic cardiac dysfunction, where rapid progression to full therapeutic intensity is critical to prevent condition deterioration.

Innovation Solution

A method and system for efficiently titrating neurostimulation therapy by gradually increasing stimulation intensity using a protocol that manages parameter changes, including output current, frequency, pulse width, and duty cycle, with intermediate holds for patient adaptation and side effect management, allowing for automated titration between clinical evaluations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If traditional manual titration process is used, then patient comfort and side effect management are improved, but titration time and treatment delay increase

Engineering Contradiction:
Improveside effects and patient discomfortVSAvoidtitration time
Core Design Contradiction:
Object-affected harmful factorsVSLoss of time

Solution Approach 1:

The system performs preliminary actions by automatically managing titration schedules, pre-calculating parameter adjustments, and proactively monitoring patient responses before clinical visits occur. This allows the system to prepare optimal stimulation parameters in advance, reducing the need for extended manual titration while maintaining patient comfort through predictive adjustments.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system implements continuous feedback loops where patient responses to stimulation are monitored in real-time, and this data feeds back into automatic parameter adjustments. The system uses this feedback to dynamically optimize titration speed, accelerating the process when patient tolerance is high while maintaining comfort when side effects are detected, thus resolving the contradiction between speed and comfort.

Inventive Principle:
Principle #23Feedback

2Reliability

If full therapeutic intensity is delivered immediately, then treatment effectiveness is improved, but patient discomfort and side effects increase

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidpatient discomfort and side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system applies dynamic adjustments to stimulation parameters based on real-time patient responses and accumulated data. Rather than static incremental increases, the system continuously adapts the titration rate and parameter changes, allowing faster progression to full therapeutic intensity when patient tolerance permits, while automatically slowing down or reducing intensity when side effects are detected, thus achieving both effectiveness and comfort.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system utilizes multiple parameter changes (amplitude, pulse width, frequency, duty cycle) in coordinated fashion to reach full therapeutic intensity more efficiently. By strategically modifying multiple parameters simultaneously or sequentially based on patient response, the system can achieve effective treatment levels faster than traditional single-parameter incremental approaches, while maintaining patient comfort through optimized parameter combinations.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If frequent clinical visits are scheduled for titration adjustments, then patient comfort and monitoring are improved, but patient convenience and resource utilization worsen

Engineering Contradiction:
Improvepatient comfort and monitoring qualityVSAvoidpatient convenience
Core Design Contradiction:
Object-affected harmful factorsVSEase of operation

Solution Approach 1:

The system enables self-service by allowing patients to actively participate in their own titration process through mobile device interactions. Patients can report symptoms, adjust parameters within predefined ranges, and receive real-time feedback without requiring constant physician intervention. This self-monitoring and self-adjustment capability maintains patient comfort and monitoring quality while significantly reducing the frequency of required clinical visits, thereby improving patient convenience.

Inventive Principle:
Principle #25Self-service

4Productivity

If automated titration is implemented, then titration speed and efficiency are improved, but system complexity increases

Engineering Contradiction:
Improvetitration speedVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system achieves high titration speed and automation while managing complexity by implementing multi-functionality in a unified platform. The neurostimulator integrates multiple functions including automatic parameter adjustment, real-time patient response monitoring, data storage and analysis, wireless communication, and adaptive algorithm execution within a single device. This consolidation avoids the need for multiple separate complex systems, enabling fast automated titration while keeping the overall system architecture manageable and clinically usable.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12263343B2Neurostimulator with titration assist
Publication Date: 2025.04.01 LIVANOVA USA INC
  • US12263343B2 patent drawing
  • US12263343B2 patent drawing
  • US12263343B2 patent drawing

AI summary

A method of neurostimulation titration includes titrating a neurostimulation signal from a first set of parameters toward a target set of parameters according to a titration aggressiveness profile having a titration hold point. The method further includes receiving a hold indicator indicating that the titration has reached the titration hold point. The method further includes initiating an intermediate hold of the titrating of the neurostimulation signal in response to receiving the hold indicator. The method further includes receiving an indication of a titration resumption that discontinues the intermediate hold.